Shanghai Yihe Hanyang New Materials

The firm invests balance-sheet capital from its industrial parent into early-stage material-science and chemical-engineering companies. Its mandate is strategic rather than purely financial: investments must offer technology or production capabilities that the parent can integrate into existing manufacturing lines. This includes novel polymers, specialty chemical formulations, and process innovations relevant to Chinese industrial supply chains.

The firm is unlikely to invest in consumer internet, enterprise software, or financial services — sectors with no clear adjacency to advanced-materials manufacturing. Its corporate-parent mandate narrows the investable universe to hard-science domains: specialty chemicals, polymer science, composites, coatings, and possibly adjacent equipment manufacturers serving those industries.

Corporate venture arms of this profile source predominantly through parent-company supply chains, R&D partnerships with Chinese universities, and regional science-park tenancy programs. Shanghai's concentration of chemical-engineering institutes — including East China University of Science and Technology — provides a talent and deal pipeline that foreign VCs rarely access directly.

No co-investment activity with external venture capital or private equity firms is publicly recorded. Chinese corporate venture arms pursuing strategic manufacturing integration often prefer sole or control positions that protect technology transfer, making syndicated co-investments with financial sponsors less common than in the consumer-tech venture market.